Subscribe to our newsletter to learn in depth about our areas of expertise
Corporate
Research means asking questions, living with uncertainty, getting things wrong and trying again. Research takes courage, especially at the beginning, when you are taking your first steps in the field. On 5 and 6 October, the XVII IMIBIC Young Investigator Meeting brought together a new generation of researchers for two days of scientific talks, thematic …
Artificial Intelligence
Artificial intelligence is already part of many business conversations. We talk about automation, productivity, data analysis, content creation, customer service and internal efficiency. However, its impact goes far beyond the way organisations work. AI is also changing how we search for information, compare options and discover companies, suppliers, technologies and solutions. In this new era, …
Biomedicine
Real-time PCR applications in molecular monitoring, biomarker analysis and biomedical research Fast, sensitive and quantitative, real-time PCR (qPCR) remains an essential tool in biomedical laboratories. Its value goes beyond detecting a molecular alteration: qPCR can also quantify it and track how it changes over time, providing useful information for diagnosis, patient monitoring and research. qPCR …
Biomedicine
Key considerations when choosing between RUO, Medical Device and IVD solutions based on intended use and laboratory requirements. Choosing laboratory equipment is not only about technical performance. Intended use, the working environment and regulatory requirements are also essential when selecting the right configuration. Not Every Laboratory Needs the Same Solution Choosing between RUO, Medical Device …
Biomedicine
Automated NGS in oncology to accelerate genomic analysis, reduce hands-on time and deliver faster results with Ion Torrent Genexus. Precision medicine requires fast, reliable and actionable results. In this context, automated NGS in oncology has become a key tool for accelerating genomic analysis and supporting decision-making in the laboratory. The Ion Torrent Genexus system is …
Corporate
Biomol’s growth in Spain and Portugal is not driven solely by the opening of new markets or the achievement of strategic agreements. Above all, it is built through an active presence, trusted relationships and a way of working that places proximity at the heart of every project. June offered a particularly meaningful expression of this …
Biomedicine
A precise and reproducible technology to assess safety, efficacy and quality in CAR-T products and advanced therapies. Vector Copy Number quantification by dPCR has become a key analytical tool in the development, characterization and quality control of CAR-T therapies. This parameter measures the average number of integrated vector copies per cell. Therefore, it provides essential …
Congresses
Biomol took part as a sponsor in the XX SEFIN Congress 2026. This scientific meeting focused on biological nitrogen fixation and beneficial interactions between plants and microorganisms. In addition, Fundación Instituto Biomol awarded three grants to support the attendance of young researchers. Last May, the XX SEFIN Congress 2026 was held in Cádiz. The event …
Biopsy
An integrated approach to improving molecular characterization, disease monitoring and clinical decision-making in oncology. Precision medicine has transformed the approach to cancer. It promotes the use of increasingly sensitive molecular tools to characterize disease, monitor progression and support clinical decision-making. In this context, the integration of liquid biopsy, pathology and oncohematology represents a key advance. …
Cámara de Comercio
April was a highly active period for Biomol. In this Biomol April 2026 activity review, we look back at the main corporate, scientific and business milestones that strengthened the company’s presence in the biomedical sector. On one hand, Biomol took part in leading national congresses. On the other hand, the company reinforced its relationship with …
